Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.830
+0.050 (2.81%)
Jan 29, 2026, 10:36 AM EST - Market open

Revenue by Product

Millions EUR. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Research and Development of Pharmaceutical Products
20.12M
Log In
Log In
Log In
Log In
Upgrade
Research and Development of Pharmaceutical Products Growth
-67.36%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
France
20.12M
Log In
Log In
Log In
Log In
Upgrade
France Growth
-67.36%
Log In
Log In
Log In
Log In
Upgrade